Bioimplant formulation

Details Bioimplant formulation Bioimplant formulation

2005-07-05

2005-07-05

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S450000, C514S012200, C514S014800, C514S015800, C514S016700, C514S017400, C514S018700, C514S019300, C514S513000, C514S515000, C530S328000

Reexamination Certificate

active

06913761

ABSTRACT:
A pharmaceutical and/or veterinary formulation comprising about 2-30% (w/w) (on an active basis) of at least one active agent, about 0.5-20.0% (w/w) of a pore-foaming agent and the balance stearin. Such formulations provided release of the at least one active agent in humans and other animals for periods of 7 days up to about 2 years.

REFERENCES:
patent: 4578391 (1986-03-01), Kawata et al.
patent: 6337318 (2002-01-01), Trigg et al.
patent: 0 523 330 (1992-04-01), None
patent: 0 523 330 (1993-01-01), None
patent: 94/08623 (1994-04-01), None

Affiliated with

Also associated with

Rating

Bioimplant formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioimplant formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioimplant formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3371460